Skip to content

Clinical trials

Phase 4 Thrombocytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 4 Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20093
20101
20122
20132
20141
20152
20171
20181
20214
20223
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status7
Terminated5
Recruiting4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Al-Mustansiriyah University1
Amgen1
Chinese PLA General Hospital1
Encysive Pharmaceuticals1
Fayoum University Hospital1
First Affiliated Hospital Xi'an Jiaotong University1
G. d'Annunzio University1
GlaxoSmithKline1
Heinrich-Heine University, Duesseldorf1
Helwan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia26
Purpura, Thrombocytopenic, Idiopathic5
Hepatitis C2
Liver Cirrhosis2
Thrombosis2
Acute-On-Chronic Liver Failure1
Connective Tissue Diseases1
Critical Illness1
End Stage Liver Disease1
Fibrosis1

Trials

Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.